Real-World Safety and Effectiveness of Dimethyl Fumarate in Patients with MS: Results from the ESTEEM Phase 4 and PROCLAIM Phase 3 Studies with a Focus on Older PatientsYang Mao‐Draayer, Fabrizio Giuliani, Konstantin Balashov et al.|Advances in Therapy|2024Cited by 6